tiprankstipranks
Trending News
More News >
Quoin Pharmaceuticals (QNRX)
NASDAQ:QNRX
US Market

Quoin Pharmaceuticals (QNRX) Financial Statements

Compare
375 Followers

Quoin Pharmaceuticals Financial Overview

Quoin Pharmaceuticals's market cap is currently $4.76M. The company's EPS TTM is $; its P/E ratio is -0.27; Quoin Pharmaceuticals is scheduled to report earnings on March 12, 2026, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24Dec 23Dec 22Dec 21Dec 20
Income Statement
Total Revenue$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Operating Income$ -9.53M$ -9.38M$ -9.26M$ -6.06M$ -1.67M
EBITDA$ -9.43M$ -9.27M$ -8.56M$ -20.27M$ -1.57M
Net Income$ -8.96M$ -8.69M$ -9.38M$ -21.46M$ -2.10M
Balance Sheet
Cash & Short-Term Investments$ 14.06M$ 10.69M$ 12.85M$ 7.48M$ 323.83K
Total Assets$ 15.71M$ 12.17M$ 14.46M$ 9.36M$ 1.38M
Total Debt$ 0.00$ 0.00$ 0.00$ 0.00$ 1.21M
Net Debt$ -3.62M$ -2.40M$ -2.86M$ -7.48M$ 889.48K
Total Liabilities$ 6.50M$ 6.51M$ 7.05M$ 8.70M$ 7.99M
Stockholders' Equity$ 9.20M$ 5.66M$ 7.41M$ 657.03K$ -6.61M
Cash Flow
Free Cash Flow$ -7.86M$ -7.86M$ -8.73M$ -6.35M$ -1.46M
Operating Cash Flow$ -7.86M$ -7.86M$ -8.48M$ -5.72M$ -1.34M
Investing Cash Flow$ -1.89M$ 2.19M$ -10.15M$ -625.00K$ -125.00K
Financing Cash Flow$ 10.97M$ 5.22M$ 14.01M$ 13.50M$ 1.79M
Currency in USD

Quoin Pharmaceuticals Earnings and Revenue History

Quoin Pharmaceuticals Debt to Assets

Quoin Pharmaceuticals Cash Flow

Quoin Pharmaceuticals Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.